InspireMD (NASDAQ:NSPR) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, August 6th. Analysts expect the company to announce earnings of ($2.00) per share for the quarter.
InspireMD (NASDAQ:NSPR) last announced its earnings results on Tuesday, May 14th. The company reported ($3.82) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($2.50) by ($1.32). The company had revenue of $0.42 million during the quarter, compared to analyst estimates of $1.10 million.
NSPR stock traded down $0.13 during trading hours on Friday, hitting $3.17. 2,958 shares of the stock traded hands, compared to its average volume of 134,008. The firm has a 50-day moving average of $3.37. InspireMD has a one year low of $3.00 and a one year high of $15.35.
InspireMD, Inc, a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions.
Recommended Story: Why are percentage gainers important?
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.